Is Genomic Risk Stratification useful for Patients with early HR+/ERBB2 Breast Cancer?

被引：0
|
作者：
Lichert, Frank
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：474 / 474
页数：1
相关论文
共 50 条
  • [41] Adjuvant Therapy of HR+, HER2 Breast Cancer Prolonging Survival without invasive Disease in high-risk early Breast Cancer
    Ruedesheim, Sabine M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (7-8)
  • [42] Genomic tests for risk stratification in patients with early human epidermal growth factor receptor 2-positive breast cancer
    Giachetti, Pier Paolo M. Berton
    Giordano, Elisa
    Salimbeni, Beatrice Taurelli
    Trapani, Dario
    Curigliano, Giuseppe
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (06) : 480 - 486
  • [43] Ribociclib effective in HR+, HER2– breast cancer
    Sidaway P.
    Nature Reviews Clinical Oncology, 2018, 15 (9) : 532 - 532
  • [44] The ErbB2 signaling network as a target for breast cancer therapy
    Badache, Ali
    Goncalves, Anthony
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2006, 11 (01) : 13 - 25
  • [45] Brk is coamplified with ErbB2 to promote proliferation in breast cancer
    Xiang, Bin
    Chatti, Kiranam
    Qiu, Haoqun
    Lakshmi, B.
    Krasnitz, Alexander
    Hicks, Jim
    Yu, Min
    Miller, W. Todd
    Muthuswamy, Senthil K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (34) : 12463 - 12468
  • [46] MiR-34a modulates ErbB2 in breast cancer
    Wang, Yilin
    Zhang, Xiaolong
    Chao, Zou
    Kung, Hsiang-Fu
    Lin, Marie C.
    Dress, Andreas
    Wardle, Fiona
    Jiang, Bing-Hua
    Lai, Lihui
    CELL BIOLOGY INTERNATIONAL, 2017, 41 (01) : 93 - 101
  • [47] Abemaciclib for the treatment of HR+/HER2- breast cancer
    Exman, Pedro
    Tolaney, Sara M.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2018, 3 (03): : 151 - 161
  • [48] The ErbB2 Signaling Network as a Target for Breast Cancer Therapy
    Ali Badache
    Anthony Gonçalves
    Journal of Mammary Gland Biology and Neoplasia, 2006, 11 : 13 - 25
  • [49] The potential role of the EGFR/ERBB2 heterodimer in breast cancer
    Cicenas, Jonas
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (06) : 607 - 616
  • [50] Prognosis in hormon receptor negative breast cancer patients according to ERBB2 status
    Dogan, L.
    Atalay, C.
    Yilmaz, K. B.
    Ozaslan, C.
    NEOPLASMA, 2008, 55 (06) : 544 - 548
12345